Combination Treatment of Difelikefalin and Tolvaptan for Late-Stage Polycystic Kidney Disease: TH-PO446

Authors

Ashlyn Y. Anderson, LSU Health Sciences Center - New OrleansFollow
Daniel Kapusta, LSU Health Sciences Center - New OrleansFollow
Kara Johnson, LSU Health Sciences Center - New OrleansFollow
Madison Grace Haggard, LSU Health Sciences Center - New Orleans
Jacob K. Meariman, LSU Health Sciences Center - New OrleansFollow
Ian B. Denys, LSU Health Sciences Center - New OrleansFollow
Mihran V. Naljayan, LSU Health Sciences Center - New OrleansFollow
Juan Gao, LSU Health Sciences Center - New OrleansFollow

Document Type

Conference Proceeding

Publication Date

10-1-2023

Publication Title

Journal of the American Society of Nephrology

Abstract

American Society of Nephrology - Kidney Week; October 24 - 27; San Diego, CA

Volume

35

Issue

S

Publisher

American Society of Nephrology

Comments

TH-PO446

Rights

© 2024 by the American Society of Nephrology

Recommended Citation

Anderson, Ashlyn Y.; Kapusta, Daniel; Johnson, Kara; Haggard, Madison Grace; Meariman, Jacob K.; Denys, Ian B.; Naljayan, Mihran V.; and Gao, Juan, "Combination Treatment of Difelikefalin and Tolvaptan for Late-Stage Polycystic Kidney Disease: TH-PO446" (2023). School of Medicine Faculty Publications. 4437.
https://digitalscholar.lsuhsc.edu/som_facpubs/4437
10.1681/ASN.20246n1gzbf9